Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report

Research and Markets logo

Dublin, July 14, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( has announced the addition of the "Point of Care Testing 2014: Applications for Microfluidic Technologies" report to their offering.

POC testing based on microfluidic technology is expected to grow sharply, from $1.6B in 2013 to $5.6B in 2019, at a CAGR 2014 - 2019 of 23%. Major diagnostics companies (Alere, Abbott Point of Care, BD Diagnostics, Cepheid, Abaxis, etc.) have realized the potential of rapid molecular diagnostic testing.

Indeed, several successful Point of Care products based on microfluidic technology have been launched in the past few years. Access to microfluidic technologies for diagnostic companies often passes through acquisitions, as this reduces the technology development risk and increases reactivity. The most recent acquisition was that of IQuum by Roche for $275M in April 2014.

Based on a complete analysis of the last three years' developments, we have been able to draw effective conclusions. Despite slower than expected growth in 2012, we explain why strong future growth is still likely.

POC 2014 report describes the following applications:

  • Emergency testing
  • Home tests
  • Doctor's office screening
  • Decentralized hospital tests
  • Environmental testing
  • Forensic and military
  • Third-world infections
  • Agro-food

Each of these are explained using market data, trends and drivers, key players and technologies used.

Also, growth perspectives and a value chain analysis are detailed for each application, and examples of innovative products are provided.

Moreover, this new report provides an overview of nearly 65 new technologies (commercialized or close to market), with information regarding commercial status, targeted application, technology description, sample volume, sensitivity level and target price

Key Topics Covered:

Executive summary


The market for Point of Care diagnostics

What's happened since 2011?

Market segmentation

Point of Care technologies

Success stories analysis

POC challenges

Supply and value chain


Summary and conclusions

Companies Mentioned:

  • 3M
  • Abaxis
  • Abbott Point of Care
  • Accumetrics
  • Achira
  • Akonni Biosystems
  • Alere
  • Ativa
  • Bio-Rad
  • BioCartis
  • Biodetection Instruments
  • Cepheid
  • Curetis
  • DNA Electronics
  • Daktari
  • Enigma Diagnostics
  • F-Cubed
  • Focus Diagnostic
  • GenePOC
  • Genefluidics
  • Great Basin
  • Handylab (BD)
  • IBM
  • INO
  • Ikerlan
  • Iquum
  • Johnson & Johnson (Amic)
  • LeukoDX
  • Lumora
  • MIT Lincoln Laboratory
  • Medimate
  • Molbio Diagnostics
  • Molecular Vision (Abingdon Health)
  • Nanosphere
  • NetBio
  • Norchip
  • OPKO Diagnostics
  • OcuSense
  • On-Chip Biotechnologies
  • Pall Corporation
  • Philips
  • Rheonix
  • Roche
  • STMicroelectronics
  • Siemens
  • Smiths Detection
  • Sony (Micronics)
  • SpinChip Diagnostics AS
  • ThermoFisher
  • Vista Therapeutics
  • Wako Diagnostics
  • Zyomyx Inc
  • bioMérieux

For more information visit

CONTACT: Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Diagnostics, Point-of-Care Diagnostics

Source:Research and Markets